Opening book details…
Can I read U.S. Biopharmaceuticals: What To Expect Next Week in SF on EtoBox?
U.S. Biopharmaceuticals: What To Expect Next Week in SF by Geoff Meacham, Ph.D. is a book available to read on EtoBox.
What is U.S. Biopharmaceuticals: What To Expect Next Week in SF about?
Page 1 1 Overview 1 Disclosure 1 Page 2 3 Table Title: CONTENTS 3 Page 3 4 Table Title: Price/Rating Analysis 4 Johnson & Johnson 4 What We Expect to Hear 4 What We Don’t Expect to Hear 4 Our Take 4 Table Title: FIGURE 1 JNJ Presentation Expectations and 4Q18 and 2019 Consensus vs. Barclays Estimates 4 Page 4 5 Pfizer 5 Table Title: Price/Rating Analysis 5 What We Don’t Expect to Hear 5 Our Take 5 Table Title: FIGURE 2 Pfizer Presentation Expectations and 4Q18 and 2019 Consensus vs. Barclays Estimates 5 Page 5 6 Table Title: Price/Rating Analysis 6 Merck & Co. 6 What We Expect to Hear 6 What We Don’t Expect to Hear 6 Our Take 6 Table Title: FIGURE 3 Merck Presentation Expectations and 4Q18 and 2019 Consensus vs. Barclays Estimates 6 Page 6 7 Table Title: Price/Rating Analysis 7 Amgen 7 What We Expect to Hear 7 What We Don’t Expect to Hear 7 Our Take 7 Table Title: FIGURE 4 Amgen Presentation Expectations and 4Q18 and 2019 Consensus vs. Barclays Estimates 7 Page 7 8 Table Title: Price/Rating Analysis 8 Gilead 8 What We Expect to Hear 8 What We Don’t Expect to Hear 8 Our Take 8 Table Title: FIGURE 5 Gilead Presentation Expectations and 4Q18 and 2019 Consensus vs. Barclays Estimates 8
- Author
- Geoff Meacham, Ph.D.
- Language
- EN